Abstract:Previous studies have shown that there is a high frequency of loss of heterozygosity (LOH) on chromosome 17p13.3 in hepatocellular carcinoma [HCC (M. Fujimori et al., Cancer Res., 51: 89-93, 1991; H. Nagai et al., Oncogene, 14: 2927-2933, 1997; V. Boige et al., Cancer Res., 57: 1986-1990, 1997; Z. Piao et al., Int. J. Cancer, 75: 29-33, 1998; and B. Charroux et al., J. Cell Biol., 148: 1177-1186, 2000)]. The minimum region of LOH on chromosome 17p13.3 in HCC has been defined within the region between D17S643 and D17S1574. Moreover, D17S926 in the minimum region of LOH has the highest frequency of LOH, and its sequencing analysis has been accomplished. In this region, 6 of 13 novel genes have been characterized (X. Zhao, D. Wan, M. He, Yu. Ye, Yi. He, L. Han, M. Guo, Y. Huang, W. Qin, M-W. Wang, W. Chong, J. Chen, L. Zhang, N. Yang, B. Xu, M. Wu, L. Zuo, and J. Gu. A high frequency LOH region on chromosome 17p13.3 in human HCC with densely clustered genes identified, submitted for publication). Here we describe the cloning and characterization of one of these novel genes, designated HCC suppressor 1 (HCCS1), located at this region. HCCS1 had 18 exons, and its full-length cDNA was 2.0 kb. The protein expression product of HCCS1 was located in mitochondria. HCCS1 had a high frequency of mutations in HCC samples, whereas no alteration has been found in matched noncancerous liver tissues. Immunohistochemistry revealed a significantly higher expression of HCCS1 in the noncancerous liver tissues (33 of 35 samples) than in the HCC samples (2 of 35 samples). Transfection of HCCS1 cDNA into the HCC cell line remarkably reduced the efficiency of its colony formation and inhibited tumor growth in nude mice. Taken together, these findings strongly suggest a potential role of HCCS1 as a HCC putative suppressor gene.

The minimum LOH region defined on chromosome 17p13.3 in human hepatocellular carcinoma with gene content analysis.

[Analysis on Loss of Heterozygosity of Chromosome 17p13.3 in Hepatocellular Carcinoma and Construction of Genomic Contig in the Deleted Region].

Deletion of Chromosomes 9p and 17 Associated with Abnormal Expression of P53, P16/Mts1 and P15/Mts2 Gene Protein in Hepatocellular Carcinomas

Loss of Heterozygosity on Chromosome 10Q22-10Q23 and 22q 11.2- 22q 12.1 and P53 Gene in Primary Hepatocellular Carcinoma

The Association of Frequent Allelic Loss on 17p13.1 with Early Metastastic Recurrence of Hepatocellular Carcinoma after Liver Transplantation

Genetic Aberration in Primary Hepatocellular Carcinoma: Correlation Between P53 Gene Mutation and Loss-of-hetero- Zygosity on Chromosome 16Q21-Q23 and 9P21-P23

A Novel Growth Suppressor Gene on Chromosome 17p13.3 with a High Frequency of Mutation in Human Hepatocellular Carcinoma.

Ioss of Heterozygosity on Chromosomes 8 and 16 in Primary Hepatocellular Carcinoma

Loss of Heterozygosity on Chromosome 3p in Breast Cancer and Precancerous Lesion

The promoter analysis of the human C17orf25 gene, a novel chromosome 17p13.3 gene

The Association Between Methylation Patterns of DNAH17 and Clinicopathological Factors in Hepatocellular Carcinoma

Relation of HCC to Loss of Heterozygosity

Preliminary study on the loss of heterozygosity at 17p13 in gastric and colorectal cancers.

Loss of heterozygosity at chromosomal 1p36 in small hepatocellular carcinoma patients

Loss of Heterozygosity and Microsatellite Instability in Hepatocellular Carcinoma in Taiwan

Loss of heterozygosity at D8S262: an early genetic event of hepatocarcinogenesis

LOH Analysis of Genes Around D4S2964 Identifies ARD1B As a Prognostic Predictor of Hepatocellular Carcinoma.

Allelic Loss And Gain, But Not Genomic Instability, As The Major Somatic Mutation In Primary Hepatocellular Carcinoma

Significance of loss of heterozygosity chromosome 1 in hepatocellular carcinoma

Study on Loss of Heterozygosity and Microsatellite Instability in Hepatocellular Carcinoma

Loss of heterozygosity on chromosome 17p13.3 in ovarian cancer and cervical cancer